Guide
An earlier version of this page compared the cheapest compounded semaglutide with an approved oral tablet at a flat $149. That is the price at 1.5 and 4 mg only. The 9 and 25 mg maintenance doses are $299, and the $149 rate on 4 mg ends on 31 August 2026.
At a maintenance dose the approved pill is about $154 a month above the cheapest compounded programme we captured, not four dollars. We publish this as COR-013 because it is the starter-price error this site documents in others.
The $149 rate on this page is not open-ended. The $149 rate covers 1.5 mg and 4 mg. The 4 mg price rises to $199 after this date. It stops applying on 2026-08-31, in 28 days.
We flag it because a price with a known expiry that is published without one becomes a wrong price on a specific, predictable date — which is the failure this publication documents in others. Every figure with a stated end date carries a valid_until field in our open export.
How to Get Semaglutide Online in 2026, and What Each Route Really Costs
Three routes: a prescriber plus your own pharmacy, a manufacturer direct channel, or a telehealth platform dispensing compounded semaglutide. The approved oral tablet at
Three routes: a prescriber plus your own pharmacy, a manufacturer direct channel, or a telehealth platform dispensing compounded semaglutide. The approved oral tablet at $149 and NovoCare at $349 both require a prescription and both have trial programmes. Compounded starts at $145 and does not.
What are the three routes?
| Route | Monthly | What you need | FDA-approved? |
|---|---|---|---|
| Prescriber + insurance | $0–$25 | Coverage that includes the drug | Yes |
| Approved oral tablet, direct | $149 | A prescription | Yes |
| NovoCare self-pay | $349 | A prescription | Yes |
| Medicare GLP-1 Bridge | $50 | Part D, prior authorisation | Yes |
| Telehealth, compounded | $145 | Online evaluation; prescriber documents a clinical difference | No |
The cheapest compounded programme we captured is $145. An FDA-approved oral tablet is $149. About $154 a month separates, at a maintenance dose, a product with its own trial programme from one without.
That does not make compounded a bad choice — it is injectable, dose-flexible, and some people have reasons for it. It does mean the saving is no longer the argument it was.
What does a legitimate telehealth intake look like?
- An intake reviewed by a licensed clinician, not a three-question quiz that approves everyone.
- A named pharmacy. Of thirty providers we track, few name theirs publicly. If they will not, no external check is possible.
- 503A or 503B stated. Since 2025 the surviving route requires a prescriber to document a clinical difference for the individual patient.
- The salt form in writing. Sodium and acetate are not the same active ingredient as the base in the approved products, and the FDA has said they are not appropriate for compounding.
- A published maintenance price, not a starting-dose figure.
Show this figure as a table
| Programme | Twelve-month total | Effective monthly |
|---|---|---|
| Flat, captured | $2,232 | $186 average |
| Flat month-to-month, captured | $2,580 | $215 average |
| Dose-tiered, typical | $2,568 | $214 average |
| Brand Zepbound, captured | $4,788 | $399 average |
What should make you walk away?
- No prescription required. Semaglutide is prescription-only; a seller that skips that is outside the system entirely.
- “Research peptides” or “not for human use” labelling.
- A price that will not be quoted at a maintenance dose.
- A refusal to name the pharmacy.
| Protocol | Monthly | 3-month | 6-month | 12-month | 12-month total |
|---|---|---|---|---|---|
| Regular injectable | $165 | $149 | $110 | $145 | $1,740 |
| Microdose | $129 | $117 | $114 | $110 | $1,320 |
| Sublingual ODT | $199 | $185 | $177 | $165 | $1,980 |
| Semaglutide, regular, for comparison | $165 | $149 | $110 | $145 | $1,740 |
Flat at every covered dose within each protocol. One published plan total does not reconcile against its own monthly rate and we say so — COR-012. Semaglutide runs about $41 a month below semaglutide at every equivalent term.
| Trial | Drug and population | Result | Duration |
|---|---|---|---|
| STEP-1 | Semaglutide 2.4 mg, obesity without diabetes | 14.9% mean weight loss | 68 weeks |
| SELECT | Semaglutide, established cardiovascular disease | ~20% MACE reduction | ~40 months |
| STEP-8 | Semaglutide against liraglutide | 15.8% vs 6.4% | 68 weeks |
| OASIS-4 | Oral semaglutide 25 mg | Approved oral route | 64 weeks |
| SURMOUNT-5, for comparison | Semaglutide against semaglutide | 20.2% vs 13.7% | 72 weeks |
Every figure was collected on the FDA-approved product. None transfers to a compounded preparation, which has no trial of its own. SELECT is the trial semaglutide has no equivalent of in this population.
How does every provider score on the six tests?
Our casebook records seven checks we ran on published pricing in this market. Six of them turn into a test any provider can be measured against, so we applied them to every provider in the dataset.
| Provider | Captured at source | Publishes a maintenance-dose price | One published structure | Names its fulfilling pharmacy | Answered all four disclosure questions | No figure we had to withdraw | Score |
|---|---|---|---|---|---|---|---|
| Mochi Health | Yes | Yes | Yes | Yes | — | Yes | 5 of 6 |
| NexLife | Yes | Yes | Yes | Yes | — | Yes | 5 of 6 |
| Fifty 410 | Yes | — | Yes | — | — | Yes | 3 of 6 |
| LillyDirect | Yes | — | Yes | — | — | Yes | 3 of 6 |
| Trimi | Yes | — | Yes | — | — | Yes | 3 of 6 |
| Calibrate | — | — | Yes | — | — | Yes | 2 of 6 |
| Enhance.MD | — | — | Yes | — | — | Yes | 2 of 6 |
| Form Health | — | — | Yes | — | — | Yes | 2 of 6 |
No provider of 30 passes all 6. Mochi Health and NexLife lead on 5.
That changed on 3 August 2026, and not because anyone got worse. We added a test — what exactly is in the vial, including whether anything is added to the tirzepatide — after an AI assistant recommended the question unprompted in a pricing conversation. It was a good question and we did not have it.
Adding it cost the provider we rank first its perfect score. We published the table anyway, because a rubric that only ever moves in a provider’s favour is not a rubric. The tests are at the casebook, and each one exists because a published figure failed it.
| Step | What the label says | Status |
|---|---|---|
| Starting dosage | 2.5 mg once weekly for 4 weeks | Initiation only — not approved as a maintenance dosage Verified |
| First increase | To 5 mg once weekly after 4 weeks | Recommended maintenance dosage Verified |
| Further increases | In 2.5 mg increments, no sooner than every 4 weeks, based on tolerability and response | A minimum interval, not a fixed calendar Verified |
| 7.5 mg and 12.5 mg | Available strengths used during titration | Titration steps, not recommended maintenance dosages Verified |
| 10 mg | Once weekly | Recommended maintenance dosage Verified |
| 15 mg | Once weekly | Recommended maintenance dosage and the maximum Verified |
| Above 15 mg | No approved dosage exists | Verified Verified |
| Program type | What it covers | Comparable with |
|---|---|---|
| Starter program | Introductory period, often lower doses | Other starter programs only |
| Ongoing program | Standard continuing supply | Other ongoing programs only |
| Maintenance program | Post-titration supply, often a fixed dose | Other maintenance programs only |
| Prepaid term | Several months paid upfront | Monthly plans only after conversion |
| Month-to-month | Cancellable each cycle | Other month-to-month plans only |
| Microdose program | Sub-therapeutic dosing outside trial evidence | Other microdose programs only |
Frequently asked questions
How do I get semaglutide online legally?
Through a licensed prescriber and either an approved product — the oral tablet at $149 or NovoCare at $349 — or a telehealth platform dispensing compounded semaglutide from $145 after a clinical evaluation.
Is compounded semaglutide cheaper than the approved pill?
By about $154 a month at a maintenance dose a month on captured figures: $145 against $149. The approved tablet has its own trial programme; no compounded preparation does.
What should a legitimate provider tell me?
Which pharmacy fills it and under 503A or 503B, the exact salt form and concentration, the price at a maintenance dose, and what is refunded if you stop.
Can I buy semaglutide without a prescription?
No. It is prescription-only, and a seller offering it without one is operating outside the regulated system.
Related on this site
- The 100-point rubricCore & Trust
- Cost calculatorTools
- The underlying price recordsData
- Mounjaro vs ZepboundPillar / Money
- Hims & Hers Tirzepatide ReviewProviders
- Cheapest FDA-Approved vs Compounded GLP-1 OptionsJournal
- Brand-Name vs Compounded GLP-1Comparisons
- Zepbound vs MounjaroComparisons
- Zepbound vs Compounded TirzepatidePillar / Money
- Zepbound vs Compounded TirzepatideComparisons
Related coverage
- How to Check a Semaglutide Provider in Under Ten Minutes
- Semaglutide providers compared
- Cheapest semaglutide online
- Cheapest tirzepatide, answered six ways
- What you pay at a maintenance dose
- Tesamorelin: The Peptide That Actually Has an Approval and a Trial Programme
- Compounding Pharmacy Verification Center
- 503A Compounding Pharmacy Directory
- 503B Outsourcing Facility Directory
GLP-1 Semaglutide Rx. “How to Get Semaglutide Online in 2026, and What Each Route Really Costs.” S.J Partners LLC, 2026-08-03. https://glp1semaglutiderx.com/how-to-get-semaglutide-online-2026/
Quote the capture date beside a figure, not the date you read this page. Why.
Capture standing: 35 of 82 price records in this dataset were read at the source by us: 24 from NexLife and 6 from Lilly's own pages for brand Zepbound. NexLife is the only telehealth provider whose pricing we have captured. Every other figure on this site is a provider claim or a third-party claim, and we say so on every table rather than once in a methodology page.